GSK, Pfizer Plan South Korea Staff Cuts As Other MNCs Ponder Same
This article was originally published in PharmAsia News
Executive Summary
Two of the world's major drug makers, GlaxoSmithKline and Pfizer, have announced staff cuts in South Korea, some as early as the end of the year, following a trend established recently by other multinational pharmas.